FF-10101 is primarily used in the field of medical research, particularly in the development of treatments for inflammatory diseases. Its application focuses on targeting specific pathways involved in inflammation, making it a potential candidate for managing conditions such as rheumatoid arthritis and other autoimmune disorders. Researchers are exploring its efficacy in modulating immune responses to reduce chronic inflammation and tissue damage. Additionally, FF-10101 is being studied for its potential role in cancer therapy, where it may help inhibit tumor growth by interfering with inflammatory processes that support cancer progression. Its precise mechanism of action and therapeutic benefits are still under investigation, but it holds promise as a novel treatment option in both immunology and oncology.